Skip to main navigation Skip to search Skip to main content

A core outcome set for studies of gestational diabetes mellitus prevention and treatment

  • Aoife M. Egan
  • , Delia Bogdanet
  • , Tomás P. Griffin
  • , Oratile Kgosidialwa
  • , Mila Cervar-Zivkovic
  • , Eugene Dempsey
  • , John Allotey
  • , Fernanda Alvarado
  • , Cheril Clarson
  • , Shamil D. Cooray
  • , Harold W. de Valk
  • , Sander Galjaard
  • , Mary R. Loeken
  • , Michael J.A. Maresh
  • , Angela Napoli
  • , Paula M. O’Shea
  • , Ewa Wender-Ozegowska
  • , Mireille N.M. van Poppel
  • , Shakila Thangaratinam
  • , Caroline Crowther
  • Linda M. Biesty, Declan Devane, Fidelma P. Dunne
  • Mayo Clinic
  • Department of Endocrinology
  • St Vincent’s University Hospital
  • University of Galway
  • Medical University of Graz
  • University College Cork
  • Barts and The London School of Medicine and Dentistry
  • Tufts Medical Center
  • University of Western Ontario
  • Lawson Health Research Institute
  • Monash Health
  • Monash University
  • University Medical Centre Utrecht
  • Erasmus MC
  • Joslin Diabetes Center
  • Harvard Medical School
  • Manchester University Hospitals NHS Foundation Trust
  • Sant’Andrea University Hospital
  • Poznan University of Medical Sciences
  • University of Graz
  • University of Birmingham
  • Liggins Institute
  • Institute for Clinical Trials
  • Infant Centre and Department of Paediatrics and Child Health

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

71 Citations (Scopus)

Abstract

Aims/hypothesis: The aim of this systematic review was to develop core outcome sets (COSs) for trials evaluating interventions for the prevention or treatment of gestational diabetes mellitus (GDM). Methods: We identified previously reported outcomes through a systematic review of the literature. These outcomes were presented to key stakeholders (including patient representatives, researchers and clinicians) for prioritisation using a three-round, e-Delphi study. A priori consensus criteria informed which outcomes were brought forward for discussion at a face-to-face consensus meeting where the COS was finalised. Results: Our review identified 74 GDM prevention and 116 GDM treatment outcomes, which were presented to stakeholders in round 1 of the e-Delphi study. Round 1 was completed by 173 stakeholders, 70% (121/173) of whom went on to complete round 2; 84% (102/121) of round 2 responders completed round 3. Twenty-two GDM prevention outcomes and 30 GDM treatment outcomes were discussed at the consensus meeting. Owing to significant overlap between included prevention and treatment outcomes, consensus meeting stakeholders agreed to develop a single prevention/treatment COS. Fourteen outcomes were included in the final COS. These consisted of six maternal outcomes (GDM diagnosis, adherence to the intervention, hypertensive disorders of pregnancy, requirement and type of pharmacological therapy for hyperglycaemia, gestational weight gain and mode of birth) and eight neonatal outcomes (birthweight, large for gestational age, small for gestational age, gestational age at birth, preterm birth, neonatal hypoglycaemia, neonatal death and stillbirth). Conclusions/interpretation: This COS will enable future GDM prevention and treatment trials to measure similar outcomes that matter to stakeholders and facilitate comparison and combination of these studies. Trial registration: This study was registered prospectively with the Core Outcome Measures in Effectiveness Trials (COMET) database: http://www.comet-initiative.org/studies/details/686/.

Original languageEnglish
Pages (from-to)1120-1127
Number of pages8
JournalDiabetologia
Volume63
Issue number6
DOIs
Publication statusPublished - 1 Jun 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Clinical diabetes
  • Core outcome set
  • Insulin therapy
  • Pregnancy
  • Systematic review

Fingerprint

Dive into the research topics of 'A core outcome set for studies of gestational diabetes mellitus prevention and treatment'. Together they form a unique fingerprint.

Cite this